1-12 of 12

All-Oral Regimen for AML Provides New Treatment Pathway
Medical Industry FeatureAll-Oral Regimen for AML Provides New Treatment Pathway

What Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?
Medical Industry FeatureWhat Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?

R/R LBCL: A Practical Guide to CAR T Referral and Coordination
Project Oncology®R/R LBCL: A Practical Guide to CAR T Referral and Coordination

Cerebral Organoid Model Transforms Glioblastoma Research
Medical Industry FeatureCerebral Organoid Model Transforms Glioblastoma Research

Treatment Decisions in mCSPC: A Review of Retrospective Real-World Evidence
Medical Industry FeatureTreatment Decisions in mCSPC: A Review of Retrospective Real-World Evidence
- advertisement

Potential for Early Intervention in 1L HR+/HER2- Advanced Breast Cancer
Medical Industry FeaturePotential for Early Intervention in 1L HR+/HER2- Advanced Breast Cancer

BRCA and HRD Biomarker Testing in Advanced Ovarian Cancer: A KOL Panel Discussion
Medical Industry FeatureBRCA and HRD Biomarker Testing in Advanced Ovarian Cancer: A KOL Panel Discussion

Evolving Treatment Approaches in EGFRm NSCLC
Medical Industry FeatureEvolving Treatment Approaches in EGFRm NSCLC

New Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma
Medical Industry FeatureNew Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma

Rise in Early-Onset Colon Cancer Being Studied Through Single-Cell Sequencing
Medical Industry FeatureRise in Early-Onset Colon Cancer Being Studied Through Single-Cell Sequencing

Key Considerations for G-CSF Administration in Patients with FN Risk
Medical Industry FeatureKey Considerations for G-CSF Administration in Patients with FN Risk
- advertisement

















































